How do you approach patients with AL amyloidosis with t(11;14) who have not achieved a hematologic complete response to induction therapy with 6 cycles of Dara-CyBorD?   

Specifically, in the setting of patients that have had a PR or VGPR and are not actively progressing. 

Answer from: Medical Oncologist at Academic Institution
Medical Oncologist at University of Chicago
Great answer - would you continue Dara if still in...
Medical Oncologist at University of Washington, Fred Hutchinson Cancer Research Center
Excellent point, and I realized I didn't comment o...
Sign in or Register to read more